CN Stock MarketDetailed Quotes

Fuan Pharmaceutical (300194)

Watchlist
  • 4.53
  • -0.07-1.52%
Market Closed Jan 16 15:00 CST
5.39BMarket Cap37.44P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fuan Pharmaceutical (300194) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Preparation521.02M56.60%
APIs and intermediates363.02M39.44%
Other business32.72M3.55%
Drug distribution and others3.75M0.41%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Pharmaceutical industry920.51M100.00%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
East China region342.37M37.19%
Central China182.26M19.80%
Southwest area114.13M12.40%
North China88.12M9.57%
South China75.46M8.20%
Exports and others48.2M5.24%
Other business32.72M3.55%
Northwest region26.57M2.89%
Northeast area10.69M1.16%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -